NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

First off, you might restart your analysis with the fact that commercially approved products sold to the public would not constitute a prerevenue company.

ooh thats right. That is why Outlook Therapeutics is now worth 175 billion because EMA and the MHRA approved LYTENAVA

Ooh darn I often mix up the M with the B